(MENAFN- GetNews) DelveInsight's "Complex Regional Pain Syndrome (CRPS) market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Complex Regional Pain Syndrome (CRPS), historical and forecasted epidemiology as well as the Complex Regional Pain Syndrome (CRPS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Complex regional pain syndrome (CRPS) is a broad term describing excess and prolonged pain and inflammation that follows an injury to an arm or leg or any part of the body. CRPS is clinically characterized by sensory, autonomic, and motor disturbances; it can affect any part of the body but occurs most often in the extremities. Complex regional pain syndrome can develop after different types of injuries, such as sprains and strains, surgeries, fractures, contusions, nerve lesions, stroke, etc.
Get FREE sample copy at:
The Complex Regional Pain Syndrome (CRPS) market report also covers emerging drugs, current treatment practices, Complex Regional Pain Syndrome (CRPS) market share of the individual therapies, current and forecasted Complex Regional Pain Syndrome (CRPS) Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current CRPS treatment practice , market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Complex Regional Pain Syndrome (CRPS) Market Key Facts
- According to DelveInsight's analysts, in the year 2017, the total prevalent case of Complex Regional Pain Syndrome (CRPS) was 310,489 in the 7MM.
- The United States, in 2017, accounted for 219,317 Complex Regional Pain Syndrome prevalent cases (highest among 7MM).
- Among the EU-5 countries, the highest number of cases of CRPS was in Germany, i.e., 21,116 cases in the year 2017, which are estimated to rise by 2030.
Key Benefits of Complex Regional Pain Syndrome (CRPS) Market Report
- Complex Regional Pain Syndrome (CRPS) market report provides an in-depth analysis of CRPS Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
- The Complex Regional Pain Syndrome market report will help in developing business strategies by understanding the CRPS Market trends & developments , key players, and future market competition that will shape and drive the Complex Regional Pain Syndrome market in the upcoming years.
- The Complex Regional Pain Syndrome (CRPS) market report covers CRPS current treatment practices , emerging drugs, market share of the individual therapies in 7 MM.
- The report provides a detailed assessment of the Complex Regional Pain Syndrome market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Complex Regional Pain Syndrome (CRPS) Market
As per Delveinsight, in 2017, the total market size of Complex Regional Pain Syndrome (CRPS) was USD 65 million for the 7MM.
The Complex Regional Pain Syndrome market is expected to be mainly driven by the rise in awareness and understanding of the disease and also the expected entry of emerging therapies. Other than this, the CRPS market may also rise due to the increased funding and R & D activities.
The Complex Regional Pain Syndrome (CRPS) market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Complex Regional Pain Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Complex Regional Pain Syndrome (CRPS) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Complex Regional Pain Syndrome (CRPS) Epidemiology
In the 7MM, the total diagnosed prevalent cases of CRPS were 150,686 cases in 2017. In EU-5 countries the highest number of diagnosed cases of CRPS was in Germany, followed by France, the United Kingdom, Italy, and Spain.
The Complex Regional Pain Syndrome (CRPS) epidemiology section covers insights about the historical and current CRPS patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Complex Regional Pain Syndrome (CRPS) Drugs Uptake and Key Market Players
The Complex Regional Pain Syndrome Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the CRPS market or expected to get launched in the market during the study period. The analysis covers Complex Regional Pain Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The pipeline developmental activity around Complex Regional Pain Syndrome is pretty scarce owing to the fact that it is poorly defined resulting in underdiagnosed and fewer treatment options, it is anticipated that with a better understanding of the condition there is going to be an upsurge in this particular segment
Complex Regional Pain Syndrome (CRPS) Companies :
Ovid Therapeutics
Takeda
AstraZeneca
Biohaven Pharmaceutical
And many others.
Complex Regional Pain Syndrome Therapies Covered in the Report Include:
Soticlestat (TAK-935/OV935)
BHV-5000
And others.
Table of Content
1. Key Insights
2. Executive Summary
3. Complex Regional Pain Syndrome (CRPS) Competitive Intelligence Analysis
4. Complex Regional Pain Syndrome (CRPS) Market Overview at a Glance
5. Complex Regional Pain Syndrome (CRPS) Disease Background and Overview
6. Complex Regional Pain Syndrome (CRPS) Patient Journey
7. Complex Regional Pain Syndrome (CRPS) Epidemiology and Patient Population
8. Complex Regional Pain Syndrome (CRPS) Treatment Algorithm, Current Treatment, and Medical Practices
9. Complex Regional Pain Syndrome (CRPS) Unmet Needs
10. Key Endpoints of Complex Regional Pain Syndrome (CRPS) Treatment
11. Complex Regional Pain Syndrome (CRPS) Marketed Products
12. Complex Regional Pain Syndrome (CRPS) Emerging Therapies
13. Complex Regional Pain Syndrome (CRPS) Seven Major Market Analysis
14. Attribute Analysis
15. Complex Regional Pain Syndrome (CRPS) Market Outlook (7 major markets)
16. Complex Regional Pain Syndrome (CRPS) Access and Reimbursement Overview
17. KOL Views on the Complex Regional Pain Syndrome (CRPS) Market.
18. Complex Regional Pain Syndrome (CRPS) Market Drivers
19. Complex Regional Pain Syndrome (CRPS) Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Complex Regional Pain Syndrome (CRPS) Epidemiology Forecast
DelveInsight's Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology in the 7MM.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address: 304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website:
MENAFN20022021003238003268ID1101633525